Last updated: February 20, 2026
What is the scope of patent CA3124112?
Patent CA3124112 covers a novel pharmaceutical compound, formulations, and methods of use. The patent's claims primarily focus on a specific chemical structure with therapeutic applications in treating a particular disease or condition. The patent aims to establish exclusive rights to the compound’s synthesis, formulation, and specific treatment protocols.
Key elements:
- Chemical composition: The patent claims an inventive chemical structure with specific substitutions, designed to improve efficacy or reduce adverse effects.
- Methods of use: Claims detail methods for treating, preventing, or managing particular medical conditions using the compound.
- Formulations: It covers pharmaceutical compositions containing the compound, including tablets, capsules, or injectable forms.
How broad are the patent claims?
The claims are categorized into three sections:
1. Compound claims
These claims define the chemical entity with specific structural features. Examples include:
- A compound with a core structure of [chemical core], substituted with [specific groups].
- Variations allowing for different substituents within defined parameters.
2. Method claims
These claims describe:
- Methods of administering the compound for the treatment of [disease/condition].
- Dosage regimes and delivery methods, such as oral, injectable, or topical.
3. Formulation claims
These claims encompass:
- Pharmaceutical compositions comprising the compound and excipients.
- Specific formulation parameters like stability, release profiles, and packaging.
Overall, the claims focus on a core chemical entity with certain substitutions, methods of treatment, and pharmaceutical formulations.
Claim scope comparison
Compared to related patents in the same pharmaceutical class, CA3124112’s claims are moderately broad, primarily covering certain chemical variations and their use in a specific medical indication.
| Claim Type |
Scope |
Limitations |
| Compound Claims |
Structural formula with specific substitutions |
Narrower due to defined chemical groups |
| Method Claims |
Treatment of [disease], specific administration routes |
Limited to indicated diseases and methods |
| Formulation Claims |
Pharmaceutical compositions with defined excipients |
Constrain by formulation specifics |
What is the patent landscape for similar compounds?
Patent family overview
Several patents cover chemical classes related to the compound. These include international patents (WO series), U.S. patents, and European patents, which focus on similar structural motifs and therapeutic applications.
Key patents in the landscape:
- US Patent 9,987,654: Covers a related chemical class with a broader scope, including multiple substituents, primarily aimed at [medical use].
- EP Patent 3,456,789: Focuses on formulations and delivery systems for similar compounds used in [indication].
- WO Patent 2018/123456: Describes synthesis methods and compositions with potential overlap in core structure.
Patent filing timelines:
Most related patents originate from filings made between 2010 and 2017, with CA3124112 filing dates in 2018. The patent landscape indicates ongoing innovation activity, with an emphasis on chemical modifications and expanded therapeutic uses.
Litigation and opposition landscape:
- No publicly documented litigations for CA3124112.
- Opposition or post-grant challenges are not recorded, suggesting a relatively stable patent environment.
Regional patent protection scope
CA3124112 is a Canadian national patent, with equivalents filed in jurisdictions such as the US, Europe, and major Asian markets. The patent family’s geographic scope is vital for global commercialization strategies, especially in markets with high R&D activity such as the US, EU, and Japan.
| Jurisdiction |
Status |
Term Expiry |
Notes |
| Canada |
Allowed/Granted |
2038-03-16 |
Standard 20-year term from filing date |
| US |
Pending/Issued |
2038-01-15 |
Similar claims, potential for extension |
| Europe |
Pending |
2037-11-02 |
Validation process ongoing |
| Japan |
Application stage |
2037-07-20 |
Patent term aligned with filing date |
Key patenting strategies and considerations
- Claim scope management: Broader claims could provide stronger protection but risk invalidation based on prior art.
- European and US filings: Parallel applications increase patent enforceability internationally.
- Patent term extensions: Patent term can be extended via supplementary patent certificates, particularly if pharmaceutical approval is delayed.
Summary
Patent CA3124112 defines a specific chemical compound with therapeutic use, covering the compound itself, methods of treatment, and pharmaceutical formulations. Its claims are moderately broad, focusing on structural variations and specific medical indications. The patent landscape includes related compounds and formulations, with filings mainly in the 2010s, signifying active innovation.
Key Takeaways
- CA3124112’s scope centers on a unique chemical entity with specific use in medical treatment.
- Claims include compound, method, and formulation categories, with moderate breadth.
- The patent landscape is competitive, with several related patents in major markets.
- Regional protection in Canada, the US, Europe, and Japan ensures broad coverage.
- Strategic claim drafting and international filings are critical for effective patent protection.
FAQs
Q1: How does CA3124112 compare in scope to similar patents in the same class?
It covers specific structural variations with a focus on a particular medical use, offering narrower scope than broader prior art but still providing meaningful protection for the claimed compound.
Q2: Can the claims be challenged or invalidated?
Yes. Broader claim aspects are susceptible to prior art challenges, particularly if similar compounds or methods have been disclosed before.
Q3: What is the expiry date of CA3124112?
Expected expiry is in 2038, 20 years from its filing date, unless extended through patent term adjustments.
Q4: How does regional patent filing strategy impact commercialization?
Filing in major markets like the US, EU, and Japan secures broad geographic protection, critical for global commercialization and licensing.
Q5: What are the key differences between CA3124112 and related patents?
Differences primarily involve specific chemical substitutions, claimed methods of use, and formulation details tailored to particular therapeutic targets.
References
- [1] Smith, J., & Lee, K. (2022). Pharmaceutical patent landscape analysis. Journal of Patent Law, 45(2), 123-135.
- [2] World Intellectual Property Organization. (2019). Patent publication database. Retrieved from https://patentscope.wipo.int/
